Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107866012 | 10786601 | 2 | F | 20150205 | 20150211 | 20150819 | PER | US-GILEAD-2015-0136399 | GILEAD | 82.00 | YR | E | F | Y | 0.00000 | 20150819 | N | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107866012 | 10786601 | 1 | PS | LETAIRIS | AMBRISENTAN | 1 | Oral | 5 MG, QD | D | NKDD | 22081 | 5 | MG | TABLET | QD | ||||
| 107866012 | 10786601 | 2 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | D | 0 | |||||||||||
| 107866012 | 10786601 | 3 | C | TEMOVATE | CLOBETASOL PROPIONATE | 1 | D | 0 | |||||||||||
| 107866012 | 10786601 | 4 | C | BUMEX | BUMETANIDE | 1 | D | 0 | |||||||||||
| 107866012 | 10786601 | 5 | C | IMDUR | ISOSORBIDE MONONITRATE | 1 | D | 0 | |||||||||||
| 107866012 | 10786601 | 6 | C | OMEPRAZOLE MAGNESIUM. | OMEPRAZOLE MAGNESIUM | 1 | D | 0 | |||||||||||
| 107866012 | 10786601 | 7 | C | CHERATUSSIN AC | CODEINE PHOSPHATEGUAIFENESIN | 1 | D | 0 | |||||||||||
| 107866012 | 10786601 | 8 | C | LACTOBACILLUS ACIDOPHILUS | LACTOBACILLUS ACIDOPHILUS | 1 | D | 0 | |||||||||||
| 107866012 | 10786601 | 9 | C | MAPAP | ACETAMINOPHEN | 1 | D | 0 | |||||||||||
| 107866012 | 10786601 | 10 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | D | 0 | |||||||||||
| 107866012 | 10786601 | 11 | C | ARISTOCORT /00031902/ | 2 | D | 0 | ||||||||||||
| 107866012 | 10786601 | 12 | C | KENALOG | TRIAMCINOLONE ACETONIDE | 1 | D | 0 | |||||||||||
| 107866012 | 10786601 | 13 | C | DESOWEN | DESONIDE | 1 | D | 0 | |||||||||||
| 107866012 | 10786601 | 14 | C | TRIDESILON | ACETIC ACIDDESONIDE | 1 | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107866012 | 10786601 | 1 | Pulmonary hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107866012 | 10786601 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107866012 | 10786601 | Nausea | |
| 107866012 | 10786601 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107866012 | 10786601 | 1 | 201410 | 201411 | 0 |